l-arginine production in Corynebacterium glutamicum : manipulation and optimization of the metabolic process
As an important semi-essential amino acid, l-arginine is extensively used in the food and pharmaceutical fields. At present, l-arginine production depends on cost-effective, green, and sustainable microbial fermentation by using a renewable carbon source. To enhance its fermentative production, various metabolic engineering strategies have been employed, which provide valid paths for reducing the cost of l-arginine production. This review summarizes recent advances in molecular biology strategies for the optimization of l-arginine-producing strains, including manipulating the principal metabolic pathway, modulating the carbon metabolic pathway, improving the intracellular biosynthesis of cofactors and energy usage, manipulating the assimilation of ammonia, improving the transportation and membrane permeability, and performing biosensor-assisted high throughput screening, providing useful insight into the current state of l-arginine production.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Critical reviews in biotechnology - 41(2021), 2 vom: 06. März, Seite 172-185 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jiang, Yan [VerfasserIn] |
---|
Links: |
---|
Themen: |
94ZLA3W45F |
---|
Anmerkungen: |
Date Completed 25.11.2021 Date Revised 25.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/07388551.2020.1844625 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317214594 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317214594 | ||
003 | DE-627 | ||
005 | 20231225162754.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/07388551.2020.1844625 |2 doi | |
028 | 5 | 2 | |a pubmed24n1057.xml |
035 | |a (DE-627)NLM317214594 | ||
035 | |a (NLM)33153325 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jiang, Yan |e verfasserin |4 aut | |
245 | 1 | 0 | |a l-arginine production in Corynebacterium glutamicum |b manipulation and optimization of the metabolic process |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.11.2021 | ||
500 | |a Date Revised 25.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a As an important semi-essential amino acid, l-arginine is extensively used in the food and pharmaceutical fields. At present, l-arginine production depends on cost-effective, green, and sustainable microbial fermentation by using a renewable carbon source. To enhance its fermentative production, various metabolic engineering strategies have been employed, which provide valid paths for reducing the cost of l-arginine production. This review summarizes recent advances in molecular biology strategies for the optimization of l-arginine-producing strains, including manipulating the principal metabolic pathway, modulating the carbon metabolic pathway, improving the intracellular biosynthesis of cofactors and energy usage, manipulating the assimilation of ammonia, improving the transportation and membrane permeability, and performing biosensor-assisted high throughput screening, providing useful insight into the current state of l-arginine production | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Corynebacterium glutamicum | |
650 | 4 | |a l-arginine | |
650 | 4 | |a fermentation | |
650 | 4 | |a metabolic engineering | |
650 | 4 | |a molecular breeding | |
650 | 7 | |a Arginine |2 NLM | |
650 | 7 | |a 94ZLA3W45F |2 NLM | |
700 | 1 | |a Sheng, Qi |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xiao-Yu |e verfasserin |4 aut | |
700 | 1 | |a Ye, Bang-Ce |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Bin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical reviews in biotechnology |d 1987 |g 41(2021), 2 vom: 06. März, Seite 172-185 |w (DE-627)NLM013758837 |x 1549-7801 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2021 |g number:2 |g day:06 |g month:03 |g pages:172-185 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/07388551.2020.1844625 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2021 |e 2 |b 06 |c 03 |h 172-185 |